期刊文献+

老年人造影剂肾病的临床危险因素分析 被引量:15

Contrast-induced nephropathy in the elderly and the correlated clinical risk factors
原文传递
导出
摘要 目的观察老年患者使用低渗非离子造影剂冠状动脉造影(CAG)检查后造影剂肾病(CIN)的发病率,并探讨老年人发生CIN的危险因素。方法老年患者195例,造影前6h和造影后12h使用静脉等渗生理盐水(1ml·kg^-1·h^-1)水化,有明显心功能衰竭患者剂量减半;测定造影前3d内和造影后第2、5天血肌酐、血清胱抑素C(cystatin C)。结果(1)195例老年患者中,发生CIN 17例(8.7%);造影后3个月,11例血肌酐恢复到术前水平;2例转变为慢性肾衰竭,但不需要肾脏替代治疗;3例肾功能持续恶化,需要维持血液净化治疗;1例因多脏器功能衰竭死亡。(2)造影后第2天血清cystatin C与造影前比较,差异无统计学意义(t=0.137,P=0.891);而造影后第2天血肌酐(89.3±33.8)μmol/L,与造影前(100.14±18.9)μmol/L比较明显下降,差异有统计学意义(t=4.776,P=0.000);造影后第5天血清cystatin C、血肌酐均恢复到术前水平。(3)发生与未发生CIN患者其性别、造影剂剂量、基线血肌酐、冠心病比例,差异无统计学意义;而年龄、基线cystatin C、糖尿病、高血压、充血性心力衰竭,差异有统计学意义。(4)多因素Logistic回归分析表明,充血性心力衰竭(OR=9.597)、糖尿病(OR=8.104)、基线cystatin C(OR=6.654)、基线血肌酐(OR=1.039)是CIN发生的临床危险因素。结论老年患者在充分水化后使用低剂量低渗非离子型造影剂,具有较高安全性;发生CIN的危险因素为充血性心力衰竭、糖尿病、基线cystatin C、基线血肌酐;血清cystatin C与血肌酐比较,预测CIN强度更高。 Objective To investigate the incidence of contrast induced nephropathy (CIN) in the elderly undergoing coronary angiography and the correlated clinical risk factors. Methods 0.9% sodium chloride (1 ml · kg^-1 · h^-1 ) was administered 6 hours before and 12 hours after contrast media administration for 195 elderly patients, and the dose of sodium chloride was half when the patients were suffering from severe congestive heart failure. The levels of serum creatinine (Scr) and cystatin C were measured 3 days before and on the 2nd, 5th day after the administration of contrast, respectively, Results (1) The incidence of CIN was 8.7% (17/195). The renal function of 11 cases recovered to baseline level 3 months after the use of contrast, 2 cases had transformation to chronic renal failure but without undergoing maintenance hemodialysis, and 3 cases were dependent on maintenance hemodialysis, while 1 case developed multiple organ dysfunction until death. (2) There was no significant difference between pre-and post-contrast administration in the level of cystatin C (t=0.137, P= 0.891). But the concentration of Scr was reduced significantly on the 2nd day compared with the baseline (t=4.776, P=0.000). Both the cystatin C and Scr recovered to the baseline on the 5th day. (3) There were no significant differences between the CIN and non-CIN group in gender, the dose of contrast, the baseline Scr, and the proportion of coronary heart disease. But there were significant differences in age, the baseline serum cystatin C, the proportions of diabetes mellitus, hypertension and congestive heart failure. (4) The clinical risk factors of CIN were the baseline Scr (OR = 1. 039), the baseline serum cystatin C (OR = 6. 654), diabetes mellitus (OR=8. 104) and congestive heart failure (OR= 9. 597) according to the analysis of logislic regression. Conclusions With the hydration and the use of low-osmolar nonionic contrast, it is safe to receive contrast examination for the elderly patients. The baseline serum levels of Scrand cystatin C, diabetes mellitus and congestive heart failure are the clinical risk factors of CIN. Compared with Scr, serum evstatin C is the more powerful predictor for the development of CIN.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2009年第11期893-896,共4页 Chinese Journal of Geriatrics
关键词 造影剂 肾病 冠状血管造影术 Contrastmedia Nephrosis Coronary angiography
  • 相关文献

参考文献12

  • 1Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Intern Radiol, 2001,12: 3-9.
  • 2李美花,范利.老年人造影剂肾病及临床相关因素分析[J].中国老年学杂志,2005,25(6):649-651. 被引量:23
  • 3PucelikovaT, Dangas G, Mehran R. Contrastinduced nephropathy. Catheteri Cardiovasc Interv, 2008, 71:62-72.
  • 4Rich MW,Crecelius CA. Incidence, risk factors, and clinical course of acute renal insuffciency after cardiac catheterization in patients 70 years of age orlder. A prospective study. Arch Intern Med, 1990, 150: 1237-1242.
  • 5Kelly AM, Dwamena B, Cronin P, et al. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med, 2008, 148:284-294.
  • 6程庆砾.老年人医院内获得性急性肾功能衰竭[J].中华老年医学杂志,2006,25(1):14-15. 被引量:5
  • 7Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneou coronary intervention and a method for risk stratification. Am J Cardiol, 2004, 93:1515-1519.
  • 8姚震.胱蛋白酶抑制剂C诊断早期肾功能损害的研究[J].检验医学与临床,2008,5(1):34-35. 被引量:26
  • 9DhamidharkaVR, Kwon G, Stevens G. Serum cystatin C is superior to serum creatinine as marker of kidney function., a meta-analysis. Am J Kidney Dis, 2002,40:221 -227.
  • 10Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis, 2001, 37:79-83.

二级参考文献16

  • 1高力丁,李兴.血半胱氨酸蛋白酶抑制剂C诊断肾功能损害的研究进展[J].医学综述,2004,10(11):693-695. 被引量:23
  • 2Altintepe L,Guney I,Tonbul Z,et al.Assessment of acute renal failure patients treated in our nephrology clinic between 1996 and 2002.Transplant Proc,2004,36:3002-3005.
  • 3Sesso R,Roque A,Vicioso B,et al.Prognosis of ARF in hospitalized elderly patients.Am J Kidney Dis,2004,44:410-419.
  • 4Sheinbaum R,Ignacio C,Safi HJ,et al.Contemporary strategies to preserve renal function during cardiac and vascular surgery.Rev Cardiovasc Med,2003,4(Suppl1):S21-S28.
  • 5Carmichael P,Carmichael A.Acute renal failure in the surgical setting.ANZJ Surg,2003,73:144-153.
  • 6Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention[J]. J Vasc Intern Radiol, 2001;12:3-9.
  • 7Berg KI. Nephrotoxicity related to contrast media[J].Scand J Urol Nephrol,2000;34:5317-22.
  • 8Aspelin P, Aubry P, Fransson SG, et al . Nephrotoxic effects in high risk patients underlying angiography[J].N Engl J Med, 2003;348:491-9.
  • 9Murphy SW,Barrett BJ,Parfrey PS.Contrast nephropathy[J].J Am Soc Nephrol, 2000;11:177-82.
  • 10Rudnick MR, Goldfarb S, Wexler L,et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients:a randomized trial. The iohexol cooperative study[J]. Kidney Int,1995;47:254-61.

共引文献51

同被引文献107

引证文献15

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部